1
Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
Condition(s):SCLC, Extensive StageLast Updated:April 12, 2022Recruiting
First-line Therapy: 5458 Clinical Trials, Page 1 of 546
Hide Studies Not Open or Pending
2
The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany
Condition(s):MelanomaLast Updated:April 9, 2018Withdrawn
3
A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation
Condition(s):Non-small Cell Lung CancerLast Updated:July 7, 2021Not yet recruiting
4
Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom
Condition(s):MelanomaLast Updated:August 6, 2019Completed
5
Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea
Condition(s):Metastatic Breast CancerLast Updated:July 1, 2022Active, not recruiting
6
A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy
Condition(s):Locally Recurrent or Metastatic Cancer of the Head and Neck; Must Have Failed First-Line TherapyLast Updated:March 14, 2007Completed
7
The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer
Condition(s):Metastatic Gastric CancerLast Updated:December 9, 2020Unknown status
8
Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease
Condition(s):Graft vs Host Disease; Blood and Marrow Transplant (BMT)Last Updated:April 9, 2020Completed
9
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
Condition(s):Lung Cancer, Non-small Cell; EGFR Gene Mutation; EGFR-TKI Resistant Mutation; Primary Resistance; Circulating Tumor DNALast Updated:October 28, 2022Recruiting
10
Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in China
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:February 7, 2022Recruiting